The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitis
Open accessAbstract
The inflammatory bowel disease ulcerative colitis (UC) frequently progresses to colon cancer. To understand the mechanisms by which UC patients develop colon carcinomas, we used a mouse model of the disease whereby administration of azoxymethane (AOM) followed by repeated dextran sulfate sodium (DSS) ingestion causes severe colonic inflammation and the subsequent development of multiple tumors. We found that treating WT mice with AOM and DSS increased TNF-alpha expression and the number of infiltrating leukocytes expressing its major receptor, p55 (TNF-Rp55), in the lamina propria and submucosal regions of the colon. This was followed by the development of multiple colonic tumors. Mice lacking TNF-Rp55 and treated with AOM and DSS showed reduced mucosal damage, reduced infiltration of macrophages and neutrophils, and attenuated subsequent tumor formation. WT mice transplanted with TNF-Rp55-deficient bone marrow also developed significantly fewer tumors after AOM and DSS treatment than either WT mice or TNF-Rp55-deficient mice transplanted with WT bone marrow. Furthermore, administration of etanercept, a specific antagonist of TNF-alpha, to WT mice after treatment with AOM and DSS markedly reduced the number and size of tumors and reduced colonic infiltration by neutrophils and macrophages. These observations identify TNF-alpha as a crucial mediator of the initiation and progression of colitis-associated colon carcinogenesis and suggest that targeting TNF-alpha may be useful in treating colon cancer in individuals with UC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Rutgeerts, P., Sandborn, W. J., Feagan, B. G., Reinisch, W., Olson, A., Johanns, J., Travers, S., Rachmilewitz, D., Hanauer, S. B., Lichtenstein, G. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050516 · Cited by 3,902
Tumorigenesis and the angiogenic switch
Bergers, G., & Benjamin, L. E. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1093 · Cited by 3,559
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Okayasu, I., Hatakeyama, S., Yamada, M., Ohkusa, T., Inagaki, Y., & Nakaya, R. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90290-h · Cited by 2,401
Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,366
Self-citationInflammatory bowel disease: Etiology and pathogenesis
Fiocchi, C. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70381-6 · Cited by 2,059
Pfeffer, K., Matsuyama, T., Kündig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Krönke, M., & Mak, T. W. (1993) · Cell · doi:10.1016/0092-8674(93)90134-c · Cited by 1,677
Aspirin Use and Reduced Risk of Fatal Colon Cancer
Thun, M. J., Namboodiri, M. M., & Heath, C. W. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252301 · Cited by 1,673
The Tumor Necrosis Factor Ligand and Receptor Families
Bazzoni, F., & Beutler, B. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342607 · Cited by 1,225
Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α
Leibovich, S. J., Polverini, P. J., Shepard, H. M., Wiseman, D. M., Shively, V., & Nuseir, N. (1987) · Nature · doi:10.1038/329630a0 · Cited by 1,210
Expression of cyclooxygenase-1 and -2 in human colorectal cancer.
Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M., & Hla, T. (1995) · PubMed · Cited by 1,126
Macrophages Regulate the Angiogenic Switch in a Mouse Model of Breast Cancer
Lin, E. Y., Li, J.-F., Gnatovskiy, L., Deng, Y., Zhu, L., Grzesik, D. A., Qian, H., Xue, X.-N., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1278 · Cited by 1,074
Nozawa, H., Chiu, C., & Hanahan, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601807103 · Cited by 923
Prostaglandin E 2 Promotes Colon Cancer Cell Growth Through a G s -Axin-ß-Catenin Signaling Axis
Castellone, M. D., Teramoto, H., Williams, B. O., Druey, K. M., & Gutkind, J. S. (2005) · Science · doi:10.1126/science.1116221 · Cited by 883
Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis
Moore, R. J., Owens, D. M., Stamp, G., Arnott, C., Burke, F., East, N., Holdsworth, H., Turner, L., Rollins, B., Pasparakis, M., et al. (1999) · Nature Medicine · doi:10.1038/10552 · Cited by 839
Yoshida, S., Ono, M., Shono, T., Izumi, H., Ishibashi, T., Suzuki, H., & Kuwano, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.4015 · Cited by 696
Kune, G. A., Kune, S., & Watson, L. F. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym193 · Cited by 654
Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice
Sonoshita, M., Takaku, K., Sasaki, N., Sugimoto, Y., Ushikubi, F., Narumiya, S., Oshima, M., & Taketo, M. M. (2001) · Nature Medicine · doi:10.1038/nm0901-1048 · Cited by 587
Self-citationRock, C. S., & Lowry, S. F. (1991) · Journal of Surgical Research · doi:10.1016/0022-4804(91)90146-d · Cited by 503
Pathology of mouse models of intestinal cancer: Consensus report and recommendations
Boivin, G. P., Washington, K., Yang, K., Ward, J. M., Pretlow, T. P., Russell, R., Besselsen, D. G., Godfrey, V. L., Doetschman, T., Dove, W. F., et al. (2003) · Gastroenterology · doi:10.1053/gast.2003.50094 · Cited by 496
Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis
Ullman, T., Croog, V., Harpaz, N., Sachar, D., & Itzkowitz, S. (2003) · Gastroenterology · doi:10.1016/j.gastro.2003.08.023 · Cited by 374
Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis.
Mutoh, M., Watanabe, K., Kitamura, T., Shoji, Y., Takahashi, M., Kawamori, T., Tani, K., Kobayashi, M., Maruyama, T., Kobayashi, K., et al. (2002) · PubMed · Cited by 362
Kune, G. A., Kune, S., & Watson, L. F. (1988) · PubMed · Cited by 352
Wang, D., Wang, H., Shi, Q., Katkuri, S., Walhi, W., Desvergne, B., Das, S. K., Dey, S. K., & DuBois, R. N. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.011 · Cited by 340
Seno, H., Oshima, M., Ishikawa, T., Oshima, H., Takaku, K., Chiba, T., Narumiya, S., & Taketo, M. M. (2002) · PubMed · Cited by 327
Self-citationGene mutations and altered gene expression in azoxymethane‐induced colon carcinogenesis in rodents
Takahashi, M., & Wakabayashi, K. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03235.x · Cited by 304
Molecular mechanism of TNF signaling and beyond
LIU, Z.-G. (2005) · Cell Research · doi:10.1038/sj.cr.7290259 · Cited by 280
Nuclear factor-κB is upregulated in colorectal cancer
Lind, D. S., Hochwald, S. N., Malaty, J., Rekkas, S., Hebig, P., Mishra, G., Moldawer, L. L., Copeland, E. M., & MacKay, S. (2001) · Surgery · doi:10.1067/msy.2001.116672 · Cited by 269
Inflammation-associated cancer: NF-κB is the lynchpin
Li, Q., Withoff, S., & Verma, I. M. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.04.003 · Cited by 268
Takayama, T., Ohi, M., Hayashi, T., Miyanishi, K., Nobuoka, A., Nakajima, T., Satoh, T., Takimoto, R., Kato, J., Sakamaki, S., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.27203 · Cited by 257
MORI, R., KONDO, T., OHSHIMA, T., ISHIDA, Y., & MUKAIDA, N. (2002) · The FASEB Journal · doi:10.1096/fj.01-0776com · Cited by 250
Self-citationPromotion of colorectal neoplasia in experimental murine ulcerative colitis.
Okayasu, I., Ohkusa, T., Kajiura, K., Kanno, J., & Sakamoto, S. (1996) · Gut · doi:10.1136/gut.39.1.87 · Cited by 230
Prostaglandin E2 Stimulates the β-Catenin/T Cell Factor-dependent Transcription in Colon Cancer
Shao, J., Jung, C., Liu, C., & Sheng, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413056200 · Cited by 214
Cyclooxygenase-2: a therapeutic target in angiogenesis
Iñiguez, M. A., Rodrı́guez, A., Volpert, O. V., Fresno, M., & Redondo, J. M. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)00011-4 · Cited by 206
Marra, F., Valente, A. J., Pinzani, M., & Abboud, H. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116753 · Cited by 197
Senzer, N., Mani, S., Rosemurgy, A., Nemunaitis, J., Cunningham, C., Guha, C., Bayol, N., Gillen, M., Chu, K., Rasmussen, C., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.227 · Cited by 195
Pai, R., Nakamura, T., Moon, W. S., & Tarnawski, A. S. (2003) · The FASEB Journal · doi:10.1096/fj.02-1011com · Cited by 177
Babbar, N., & Casero, R. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3174 · Cited by 175
Analysis of the role of chemokines in angiogenesis
Bernardini, G., Ribatti, D., Spinetti, G., Morbidelli, L., Ziche, M., Santoni, A., Capogrossi, M. C., & Napolitano, M. (2003) · Journal of Immunological Methods · doi:10.1016/s0022-1759(02)00420-9 · Cited by 172
Tumor Necrosis Factor-α Is a Potent Endogenous Mutagen that Promotes Cellular Transformation
Yan, B., Wang, H., Rabbani, Z. N., Zhao, Y., Li, W., Yuan, Y., Li, F., Dewhirst, M. W., & Li, C.-Y. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2540 · Cited by 165
Medical therapy for ulcerative colitis 2004
Hanauer, S. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.071 · Cited by 156
An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors.
Scott, K. A., Moore, R. J., Arnott, C. H., East, N., Thompson, R. G., Scallon, B. J., Shealy, D. J., & Balkwill, F. R. (2003) · PubMed · Cited by 154
Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice
Hull, M. A., Booth, J., Tisbury, A., Scott, N., Bonifer, C., Markham, A. F., & Coletta, P. L. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690224 · Cited by 132
Aspirin Use and Reduced Risk of Fatal Colon Cancer
Travers, J. D., Temple, A. R., & Gates, T. N. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205073261912 · Cited by 131
High expression of cyclooxygenase-2 in macrophages of human colonic adenoma
Bamba, H., Ota, S., Kato, A., Adachi, A., Itoyama, S., & Matsuzaki, F. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991112)83:4<470::aid-ijc6>3.0.co;2-f · Cited by 130
Liu, R., Bal, H. S., Desta, T., Behl, Y., & Graves, D. T. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050907 · Cited by 129
Dysplasia and carcinoma development in a repeated dextran sulfate sodium‐induced colitis model
Okayasu, I., Yamada, M., Mikami, T., Yoshida, T., Kanno, J., & Ohkusa, T. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2002.02853.x · Cited by 123
Kitakata, H., Nemoto‐Sasaki, Y., Takahashi, Y., Kondo, T., Mai, M., & Mukaida, N. (2002) · PubMed · Cited by 118
Self-citationHardwick, J. C. H., van den Brink, G. R., Offerhaus, G. J. A., van Deventer, S. J. H., & Peppelenbosch, M. P. (2001) · Oncogene · doi:10.1038/sj.onc.1204162 · Cited by 106
Dysplasia and Malignancy in Inflammatory Bowel Disease
Dobbins, W. O. (1984) · Annual Review of Medicine · doi:10.1146/annurev.me.35.020184.000341 · Cited by 78
Fujioka, N., Mukaida, N., Harada, A., Akiyama, M., Kasahara, T., Kuno, K., Ooi, A., Mai, M., & Matsushima, K. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.58.1.90 · Cited by 77
Self-citationSafety of tumour necrosis factor and interleukin-1 blocking agents in rheumatic diseases
Botsios, C. (2004) · Autoimmunity Reviews · doi:10.1016/j.autrev.2004.09.001 · Cited by 64
Cancer surveillance in inflammatory bowel disease: new molecular approaches
Risques, R. A., Rabinovitch, P. S., & Brentnall, T. A. (2006) · Current Opinion in Gastroenterology · doi:10.1097/01.mog.0000231812.95525.a7 · Cited by 53
Spontaneous regression of lung metastasis in the absence of tumor necrosis factor receptor p55
Tomita, Y., Yang, X., Ishida, Y., Nemoto‐Sasaki, Y., Kondo, T., Oda, M., Watanabe, G., Chaldakov, G. N., Fujii, C., & Mukaida, N. (2004) · International Journal of Cancer · doi:10.1002/ijc.20493 · Cited by 41
Self-citationShiratori, Y., Hikiba, Y., Mawet, E., Niwa, Y., Matsumura, M., Kato, N., Shiina, S., Tada, M., Komatsu, Y., Kawabe, T., et al. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2340 · Cited by 28
Cited by
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Inflammation and cancer: triggers, mechanisms, and consequences
Greten, F. R., & Grivennikov, S. I. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.025 · Cited by 3,806
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Colotta, F., Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp127 · Cited by 2,890
Cytokines in inflammatory bowel disease
Neurath, M. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3661 · Cited by 2,706
Metadata
- Authors
- Popivanova, B. K., Kitamura, K., Wu, Y., Kondo, T., Kagaya, T., Kaneko, S., Oshima, M., Fujii, C., & Mukaida, N.
- Venue
- Journal of Clinical Investigation
- Published
- 2008-01-24
- Volume
- 118
- Issue
- 2
- Pages
- 560-70
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1988139137
- Cited by
- 832
- References
- 55
- FWCI
- 32.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.